CDER ... Report to the Nation

CDER ... Report to the Nation
Author :
Publisher :
Total Pages : 52
Release :
ISBN-10 : MINN:31951D02327862P
ISBN-13 :
Rating : 4/5 (2P Downloads)

Synopsis CDER ... Report to the Nation by : Center for Drug Evaluation and Research (U.S.)

The Future of Drug Safety

The Future of Drug Safety
Author :
Publisher : National Academies Press
Total Pages : 347
Release :
ISBN-10 : 9780309103046
ISBN-13 : 0309103045
Rating : 4/5 (46 Downloads)

Synopsis The Future of Drug Safety by : Institute of Medicine

In the wake of publicity and congressional attention to drug safety issues, the Food and Drug Administration (FDA) requested the Institute of Medicine assess the drug safety system. The committee reported that a lack of clear regulatory authority, chronic underfunding, organizational problems, and a scarcity of post-approval data about drugs' risks and benefits have hampered the FDA's ability to evaluate and address the safety of prescription drugs after they have reached the market. Noting that resources and therefore efforts to monitor medications' riskâ€"benefit profiles taper off after approval, The Future of Drug Safety offers a broad set of recommendations to ensure that consideration of safety extends from before product approval through the entire time the product is marketed and used.

Rare Diseases and Orphan Products

Rare Diseases and Orphan Products
Author :
Publisher : National Academies Press
Total Pages : 442
Release :
ISBN-10 : 9780309158060
ISBN-13 : 0309158060
Rating : 4/5 (60 Downloads)

Synopsis Rare Diseases and Orphan Products by : Institute of Medicine

Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.

Assessing the Safety of Our Nation's Drug Supply

Assessing the Safety of Our Nation's Drug Supply
Author :
Publisher :
Total Pages : 200
Release :
ISBN-10 : PSU:000065512913
ISBN-13 :
Rating : 4/5 (13 Downloads)

Synopsis Assessing the Safety of Our Nation's Drug Supply by : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

CDER ... Report to the Nation

CDER ... Report to the Nation
Author :
Publisher :
Total Pages : 44
Release :
ISBN-10 : UCR:31210013183080
ISBN-13 :
Rating : 4/5 (80 Downloads)

Synopsis CDER ... Report to the Nation by : Center for Drug Evaluation and Research (U.S.)

Medical Devices and the Public's Health

Medical Devices and the Public's Health
Author :
Publisher : National Academies Press
Total Pages : 318
Release :
ISBN-10 : 9780309212427
ISBN-13 : 0309212421
Rating : 4/5 (27 Downloads)

Synopsis Medical Devices and the Public's Health by : Institute of Medicine

Medical devices that are deemed to have a moderate risk to patients generally cannot go on the market until they are cleared through the FDA 510(k) process. In recent years, individuals and organizations have expressed concern that the 510(k) process is neither making safe and effective devices available to patients nor promoting innovation in the medical-device industry. Several high-profile mass-media reports and consumer-protection groups have profiled recognized or potential problems with medical devices cleared through the 510(k) clearance process. The medical-device industry and some patients have asserted that the process has become too burdensome and is delaying or stalling the entry of important new medical devices to the market. At the request of the FDA, the Institute of Medicine (IOM) examined the 510(k) process. Medical Devices and the Public's Health examines the current 510(k) clearance process and whether it optimally protects patients and promotes innovation in support of public health. It also identifies legislative, regulatory, or administrative changes that will achieve the goals of the 510(k) clearance process. Medical Devices and the Public's Health recommends that the U.S. Food and Drug Administration gather the information needed to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices. According to the report, the FDA's finite resources are best invested in developing an integrated premarket and postmarket regulatory framework.

Pain Management and the Opioid Epidemic

Pain Management and the Opioid Epidemic
Author :
Publisher : National Academies Press
Total Pages : 483
Release :
ISBN-10 : 9780309459570
ISBN-13 : 0309459575
Rating : 4/5 (70 Downloads)

Synopsis Pain Management and the Opioid Epidemic by : National Academies of Sciences, Engineering, and Medicine

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Approved Prescription Drug Products

Approved Prescription Drug Products
Author :
Publisher :
Total Pages : 20
Release :
ISBN-10 : UOM:39015072931663
ISBN-13 :
Rating : 4/5 (63 Downloads)

Synopsis Approved Prescription Drug Products by :

Accompanied by supplements.